Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119535) titled 'A multicenter, randomized, double-blind controlled study on the treatment of refractory depression by accelerating intermittent theta burst stimulation (a-iTBS) targeting the left primary motor cortex (M1)' on Feb. 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Affiliated Kangning Hospital of Ningbo University

Condition: Depressive

Intervention: The sham aiTBS group:Sham stimulation group

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-07

Target Sample Size: The sham aiTBS group:80;The active aiTBS group:80;

Countries of Recruitment...